Decentralized Trial Technology Insights
-
How AI/ML Is Helping Clinical Researchers Investigate Alzheimer's
7/28/2022
Like many cognitive conditions, Alzheimer’s disease can cause changes to a person’s speech and language. Artificial intelligence (AI) and machine learning scientists are working on automating speech assessments to detect the disease earlier and improve understanding of the efficacy of novel treatments.
-
Your Guide To Harnessing Clinical Trial Sensor Data Better
7/26/2022
Technological advances in wearables and sensors are speeding the development of digital measures and endpoints. This sensor data is often in native formats unique to each sensor technology and in proprietary clouds owned by the manufacturer. To address this challenge, the Digital Medicine Society released a set of open-access toolkits to support the successful scaling of sensor data to drive better clinical decisions.
-
Decentralized Clinical Trials: Are We Using The Best Terminology For Patients?
7/12/2022
There is a need within the clinical trials community for a broad term to describe clinical trials that make use of digital health tech and other methods for better accessibility to participants. However, is a single term as helpful for patients as it is for clinical trial professionals?
-
CVS Health Wants To Be Your New Clinical Research Site
7/6/2022
CVS has been a well-regarded and recognized healthcare brand that started as a pharmacy but has since migrated into a recognized and trusted healthcare company. Now CVS is hoping to expand the relationship it has with patients by moving closer into primary care and clinical trials.
-
Decentralized Clinical Trials: Key Considerations For Sites & PIs
6/21/2022
As we work to harness the benefits of hybrid and DCTs, sites and investigators must have processes that allow for the acceptance of DCTs and successful implementation. As these policies are under development, the vital viewpoints of sites and PIs are largely overlooked. This article shares these vital viewpoints of sites and PIs.
-
What Does The Future Hold For Decentralized Clinical Trials?
4/20/2022
What can we expect to see from decentralized trials in the next three years, and what are the challenges sponsor companies will need to overcome? A webinar hosted by IBM Watson hoped to answer that question and many others.
-
The Next Three Years Of Clinical Trials: DCTs, RWE, And Beyond
4/18/2022
Recent years have seen unprecedented innovation in the clinical space. Precision medicine, cell and gene therapies, decentralized trials, real-world data, and the promise of artificial intelligence (AI) and machine learning (ML) are just a few of the reasons to be excited about the future of clinical research.
-
Best Practices For Designing Patient-Centric Decentralized Clinical Trials
4/12/2022
Decentralized clinical trials are not universally applicable to all phases of a trial and therapeutic areas. The recommendations in this article may bring decentralized and hybrid trials to a more tangible and realistic view and, in essence, make them more executable.
-
2021 Clinical Research Site Survey Findings: A Year In Flux
3/24/2022
Since its inception in 2012, the Society for Clinical Research Sites (SCRS) has conducted an annual survey of clinical research site community members to derive insights, reveal trends, and ensure the site perspective is represented. This article summarizes the 2021 survey's findings.
-
How To Turn Your Clinical Supply Chain Pandemic Learnings Into New Best Practices
3/10/2022
Pivoting, navigating, and problem solving in real time during the pandemic has led to many real-time lessons that have evolved into adapted best practices in the global clinical supply space. This article discusses the new demand curve, packaging operations, IRT considerations, and more.